Federal Awards · INHALON BIOPHARMA, INC. · Award

DEVELOPING IN-007 AS A WIDELY DEPLOYABLE INHALED TREATMENT AGAINST PATHOGENS UTILIZING HUMAN ACE2 FOR VIRAL…

Award details are derived from public USAspending.gov records. Not a bid recommendation.

Award details

Award ID
HT942524C0076
Contractor
INHALON BIOPHARMA, INC.
Awarding agency
Department of Defense
Sub-agency / office
Defense Health Agency
Award amount
$2,234,650
Period of performance
Sep 23, 2024 – Dec 22, 2026
NAICS
541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC
PSC AN12
Place of performance
MORRISVILLE, NC, 275608425, USA
Competition
FULL AND OPEN COMPETITION · Set-aside: NO SET ASIDE USED. · 47 offers
Pricing
FIXED PRICE LEVEL OF EFFORT
Financial breakdown
Current value $2,234,650 · Obligated $2,234,650 · Potential value $2,234,650 · Latest action obligation $0

Public award description

DEVELOPING IN-007 AS A WIDELY DEPLOYABLE INHALED TREATMENT AGAINST PATHOGENS UTILIZING HUMAN ACE2 FOR VIRAL ATTACHMENT AND ENTRY REVISED STATEMENT OF WORK AND PRINCIPAL INVESTIGATOR CHANGE.

Most recent · Modification P00002 · Sep 4, 2025 · $0 action obligation · DEVELOPING IN-007 AS A WIDELY DEPLOYABLE INHALED TREATMENT AGAINST PATHOGENS UTILIZING HUMAN ACE2 FOR VIRAL ATTACHMENT AND ENTRY REVISED STATEMENT OF WORK AND PRINCIPAL INVESTIGATOR CHANGE. · HT942524C0076

Modification P00001 · Mar 12, 2025 · $0 action obligation · DEVELOPING IN-007 AS A WIDELY-DEPLOYABLE INHALED TREATMENT AGAINST PATHOGENS UTILIZING HUMAN ACE2 VIRTUAL ATTACHMENT AND ENTRY · HT942524C0076

Source: USAspending.gov

Find out who's winning similar federal contracts

Discover comparable awards, related contractors, and agency purchasing history.

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. Click Gemini to copy the research question when your browser allows, or use Copy question.